Human mesenchymal progenitor cells (MPCs) 
Introduction

Adult bone marrow (BM) mesenchymal progenitors cells (MPCs) or mesenchymal stem cells (MSCs), initially described as precursors of fibroblasts or stromal cells, can be isolated taking advantage of their adhesive properties and can be further expanded in culture. Previous studies demonstrated that MPC populations derived from BM are heterogeneous and contain at least two morphologically distinct subpopulations of cells: (a) spindle-shaped (SS), rapidly self-renewing MPCs and (b) flattened-shaped slowly self-renewing MPCs
. More interestingly, this subset of SS MPCs is able to preferentially engraft in mice; thus, they appear more promising tools for clinical applications [5] . Similarly, SS and flattened-shaped MPCs were also isolated from umbilical cord blood (UCB) at clonal level [6] , with SS subpopulation exhibiting high expression levels of CD90, whereas the flattened was negative for the same antigen [6] . # 
Joint first authors.
Recently, our group and others [7] [8] [9] have isolated MPCs from an alternative source, the second trimester amniotic fluid (AF), which can be obtained during routine amniocentesis without any ethical concerns [7, [10] [11] [12] . We characterized these cells based on their phenotype, multipotency, differentiation potential and on their proteomic profile, constructing a twodimensional electrophoresis proteomic database of AF-MPCs [7] . Most importantly, AF-MPCs were easily isolated and grew more rapidly under the appropriate culture conditions compared to BM-MPCs [7] . In addition, concurrent studies showed that AF-MPCs, seeded in a scaffold and exposed to osteogenic-inducing medium, were able to form bone after subcutaneous implantation in vivo, demonstrating an important role in pre-clinical studies [9] .
However, AF-MPCs represent a heterogeneous population composed of multiple categories of adherent cells based on morphological, biochemical and growth characteristics [13] [14] [15] [16] . Until now, there is no surface epitope or proposed protocol that can distinguish MPCs in vitro and in vivo [2] . Therefore, most experiments have been carried out with heterogenous populations of AF-MPCs [7, 8, 11, 12, 16] 
. Questions regarding the heterogeneity, the mobilization and homing properties of these cells in vitro and in vivo, as well as their use as carriers of therapeutic agents are still undetermined. Therefore, a large number of parameters must be taken under consideration in isolating the rapidly expanding MPCs from AF. First, an important determinant of successful stem cell therapeutic transplantation is the ability of the transplanted cells to home, migrate, efficiently engraft and repair damaged tissues. Various molecules have been shown to regulate these processes in MPCs.
Among these are the VLA-5 integrin, which comprises of ␣5 (CD49e) and ␤1 (CD29) subunits and plays key role in migration [7, 8, 11, 17] and the adhesion molecule CD44, which is highly expressed in most of the mesenchymal cell types [18, 19] . [20] , lentiviral vectors represent a highly efficient and long-term infection system for transducing stem cells, without the presence of silencing effects during multiple divisions [21] [22] [23] .
Another parameter involves the feasibility of employing genetic modifications on AF-MPCs by introducing therapeutic genes of interest. For these manipulations, apart from adenoviruses, that have been previously utilized in AF-MPCs
Herein, we have extended our previous findings [7] ,
by isolating and characterizing two different types of AF-MPCs at passage 0 based on their shape, antigen expression levels and functional properties. We named these cells according to their morphology as SS and round-shaped (RS) AF-MPCs. SS-AF-MPCs are characterized by a greater proliferation and multilineage differentiation potential, while they are exhibiting higher levels of CD90 compared to RS-AF-MPCs. Therefore, in the current experiments, we compared their molecular identity, the differentiation capacity and the in vitro adhesion properties of both subpopulations. We further analysed the migratory ability, the efficient gene modification and the perspective utilization of SS-AF-MPCs in pre-clinical studies in vivo.
Material and methods
Isolation and culture of MPCs from human AF
Human AF-MPCs were isolated from 95 AF samples, collected during scheduled amniocentesis between the 15 th and 18 th week of gestation [7] . 
Colony forming unit-fibroblast (CFU-F) assay
The 
Antibodies and flow cytometry analysis (FACS)
RS-AF-MPCs and SS-AF-
RT-PCR procedure
Differentiation assays Osteogenic differentiation
To induce osteogenic differentiation SS-AF-MPCs or RS-AF-MPCs of passage 5-7 were cultured to 60-70% confluency in osteogenic medium for 3 weeks, as described previously [7] . The differentiation potential for osteogenesis was assessed by alkaline phosphatase staining using BCIP/NBT reagent (Sigma-Aldrich), according to the manufacturer's instructions.
Adipogenic differentiation
SS-AF-MPCs or RS-AF-MPCs of passage 5-13, grown as described above,
were treated with adipogenic medium for 3 weeks, as described previously [7] . 
Chondrogenic differentiation
To induce chondrogenic differentiation, SS-AF-MPCs or RS-AF-MPCs
Hepatogenic differentiation
For hepatogenic differentiation, SS-AF-MPCs or RS-AF-
Proteomic analysis-mass spectrometry (MS)
Three samples of SS-AF-MPCs or RS-AF-MPCs of passage 5-10 were
analysed by 2D-gel electrophoresis in duplicate each, as described before [7] . Protein spots were manually excised, tryptic digested and Peptide Mass Fingerprinted [7] . Stringent criteria were used for protein identification with a maximum allowed mass error of 25 ppm (parts per million) and a minimum of five matching peptides [29] . Notably 
Western blot
Total proteins of SS-AF-MPCs and RS-AF-MPCs were separated by 10% SDS-PAGE and electroblotted to Hybond-ECL NC membrane (Amersham Biosciences, Sweden). Protein extracts were derived from a pool of three SS-AF-MPCs or RS-AF-MPCs individual samples of different passages, respectively. After blocking, membranes were incubated overnight at 4ЊC with the primary antibodies: mouse anti-human CK18 (DakoCytomation), mouse anti-human Cathepsin (BD) or mouse anti-human CK19 (DakoCytomation). Mouse anti-human ␤-actin antibody (Sigma-Aldrich) was used as a control of equal loading. Membranes were then incubated with anti-mouse HRP-conjugated secondary antibody (Santa Cruz Biotechnology Inc.) and developed by ECL (Perkin-Elmer, MA, USA) detection system. Films were scanned and images were analysed using Quantity One software (BioRad).
Lentiviral vector generation, production and transduction of SS-AF-MPCs
The four plasmid expression lentiviral system containing the pCCLsin.PPT.hPGK.GFP plasmid used for enhanced GFP expression [28] . Virus was produced by transient transfection into 293T cells, as previously described [29] 
In vivo engraftment of GFP-SS-AF-MPCs
Results
Phenotypic characterization of two different AF-MPC populations
As reported previously, BM-MSC and UCB-MSC cultures contained distinct cell types differing at shape and size [4, 6] . In this study, cell pellets from 95 second trimester AF samples were plated according to previous protocols [7] 
and then plastic adherent cells were isolated. Microscopic analysis led to the identification of two morphological different adherent MPC types in AF, termed as SS-AF-MPCs (6%, five established cell lines) and RS-AF-MPCs (94%) (Fig. 1A and B). We initially noticed that the percentage of proliferation increase in SS-AF-MPCs and RS-AF-MPCs differed during passages 5-7. A more detailed analysis revealed that SS-AF-MPCs exhibited high proliferative capacity and were passed over 45 passages to date, whereas RS-AFMPCs exhibited a significantly lower proliferative potential and reached up to passage 4-7 (Fig. 1C). More importantly, RS-AFMPCs when cultured in CM derived from SS-AF-MPCs exhibited
a statistically significant increased proliferative potential (Fig. 1C) (Fig. 1B, i) . However, at two to three passage in 94% of the sample cases of unselected cells, the RS cells were more abundant, overtaking the culture (Fig. 1B, ii) . The rest 6% of the samples represented a SS cell population (Fig. 1B, iii) that can be expanded up to passages to date with normal karyotype (Fig. S1E, i and iii) and high proliferation capacity (Fig. 1C) (Fig. 1A) (Fig. 2) . The surface marker profiles were consistent with previously reported BM, AF and UCB heterogeneous populations of MSCs [7, 9, 30, 31] . (Fig. 2) (Fig. 1B, vi) , whereas RS-AF-MPCs showed lower expression (MFI: 7.43Ϯ6.53) (Fig. 1B, v) . We further noticed that unselected cultures at passage 0 exhibited heterogeneous expression for CD90, low (MFI 1.6 Ϯ 1.45) and high (MFI 53.4 Ϯ 4.14) , which may indicated the initial co-existence of the two different populations (Fig. 1B, iv) (Fig. S1A ).
c-kit was expressed in similar very low/undetectable levels in both SS-AF-MPCs and RS-AF-MPCs populations, whereas CD146 was expressed in higher levels in RS-AF-MPCs compared to SS-AFMPCs
CD90 expression altered according to the proliferation rate of SS-AF-MPCs
In an attempt to examine a potential relation of the enhanced expression levels of CD90 in SS-AF-MPCs with the high proliferation capacity they exhibit, we performed an in vitro proliferation assay at different temperature culture conditions. It is known from classical studies that when fibroblast-like cells are cultured at lower temperature (i.e. 33ЊC), they exhibit a lower proliferation rate [32] .
Therefore, we performed proliferation analysis assay for SS-AFMPCs at 37ЊC (normal temperature conditions) and 33ЊC (low temperature conditions), respectively. The proliferation rate of SS-AF-MPCs dramatically decreased when cultured at 33ЊC for 6 days (Fig. 3A) , compared to those cultured at 37ЊC for the same period. When we examined the expression of mesenchymalrelated antigens at these time points, we observed that CD73 and CD105 levels were not altered when SS-AF-MPCs were cultured at 33ЊC (Fig. 3B) . However, CD90 expression was decreased to 60.08% Ϯ 26.4 for day 1 (Fig. 3B, i) and 62.09% Ϯ 3.65 for day 6 (Fig. 3B, ii) (Fig. 4A, ii) . (Fig. 4B, i and ii) . (Fig. 4B, i) . (Fig. 5B) . In all samples examined, the majority of the cells were positive for Oct-4 and Sox-2. (Fig. 6) . Results showed that RS-AF-MPCs exhibited an enhanced adipogenic (1.6 Ϯ 0.4 fold times increase) (Fig. 6A, iii) and reduced osteogenic (4.6 Ϯ 1.0 fold times decrease) (Fig. 6B, iii) (Fig. 6C and D) . Chondrogenesis, was determined by Alcian Blue staining of pellets (Fig. 6C) (Fig. 6D, ii) , urea production (46.5 mg/dl Ϯ 10.2) compared to SS-AF-MPCs (9.6 mg/ dl Ϯ 6.4) (Fig. 6D, iii) and high albumin expression level (12.5 Ϯ (Fig. 6D, iv) . Fig. 7A and B) . Protein spots that were found to be more than 1.5 (Table S3) . [37] and tryptophanyl-tRNA synthetase [38] [39] . Similarly, heat shock protein ␤1, exhibiting an anti-apoptotic role by former studies, was also highly expressed in SS-AF-MPCs [40, 41] . (Fig. 7D) . [28] ( Fig. 8A and B (Fig. 8C) 
(B) (i) AF-MPCs colonies morphology at p0, (ii) RS-AF-MPCs (p5) and (iii) SS-AF-MPCs (p5) morphology. Representative FACS histograms of (iv) AF-MPCs at p0, gated for CD90 expression (grey filled histograms), prior to analysis with the isotype-matched negative control (open histograms) at p0, (v) homogenous RS-AF-MPC at p5 and (vi) homogenous SS-AF-MPCs at p5 populations, respectively. (C) Comparative analysis of the percentage of proliferation of SS-AF-MPCs (blue line), RS-AF-MPCs (red line) and RS-AF-MPCs cultured in CM derived from SS-AF-MPCs
CD44 neutralizing antibody inhibited SS-AF-MPCs migration on fibronectin
Initially, a transwell migration assay was developed to determine the migration potential of SS-AF-MPCs and RS-AF-MPCs to fibronectin and laminin. Interestingly, SS-AF-MPCs migrated approximately 7.59-and 7.79-fold faster towards fibronectin and laminin, respectively, than RS-AF-MPCs (Fig. 4A, i) (P Ͻ 0.001, Student's t-test). Taking under consideration that CD44 represented an adhesion molecule, binding on fibronectin and was expressed in SS-AFMPCs in a higher level than RS-AF-MPCs according to FACS analysis (Fig. 2), we further investigated whether this elevated expression has a functional role in migration of SS-AF-MPCs. We therefore performed the same transwell migration assay after pre-incubating SS-AF-MPCs with a neutralizing antibody for CD44. Isotype non-binding antibody (IgG1) was used as a negative control. A significant decrease of 31.05%Ϯ12.13 (P Ͻ 0.05, Student's t-test) in migration capacity of SS-AF-MPCs was observed in the presence of CD44 blocking antibody
CD44 neutralizing antibody inhibited SS-AF-MPCs and RS-AF-MPCs adhesion on fibronectin and hyalouronic acid
SS-AF-MPCs and RS-AF-MPCs when tested in an in vitro adhesion assay on fibronectin and hyalouronic acid, exhibited similar adhesion properties on both matrices (Fig. 4B, i and ii non-treated cells). To analyse in detail the role of CD44 adhesion molecule, which binds to fibronectin and also to hyalouronic acid [33], we examined whether CD44 controlled not only the high migration capacity of SS-AF-MPCs as shown before, but also the adhesion of both populations to the respective binding matrices. Blocking of CD44 resulted in lower adhesion of both SS-AF-MPCs and
Fig. 2 Comparison of SS-AFMPCs and RS-AF-MPCs expression patterns. (A) Representative FACS histograms of SS-AF-MPCs (grey filled histograms) and RS-AF-MPCs (opened histograms) gated for (i) CD166, (ii) CD73, (iii) CD146, (iv) CD105, (v) CD44 and (vi) CD49e markers, prior to analysis with (vii) the isotype-matched negative control. (B) SS-and RS-AF-MPCs analysed for different antigens expression by FACS analysis. The statistics were made on the mean MFI for each antigen. Isotype matched negative controls were used. Values are shown as mean Ϯ S.D. for three independent samples from each type. Statistical analysis was performed using the Student's t-test (*P Ͻ 0.05).
RS-AF-MPCs on fibronectin at approximately 48% (P Ͻ 0.05, Student's t-test) and 31.3% (P Ͻ 0.05, Student's t-test), respectively (Fig. 4B, i). However, only SS-AF-MPCs exhibited impaired adhesion on hyaluronic acid in the presence of CD44 blocking antibody, (37.9%, P Ͻ 0.05, Student's t-test). There was no significant effect on cell adhesion using the IgG1 antibody compared to the non treated cells in both matrices
CD49e modulated SS-AF-MPCs and RS-AF-MPCs adhesion properties
Both cell types express the CD49e molecule which binds to fibronectin, as determined by FACS analysis (Fig. 2). For examining the role of CD49e on fibronectin-mediated adhesion, we analysed SS-AF-MPCs and RS-AF-MPCs in an in vitro adhesion assay. We observed an approximately 87% (P Ͻ 0.001, Student's t-test) and 68.9% (P Ͻ 0.001, Student's t-test) reduction on adhesion ability of SS-AF-MPCs and RS-AF-MPCs, respectively, in the presence of CD49e blocking antibody, compared to non-treated cells
SS-AF-MPCs expressed oct-4, nanog and sox-2 in higher levels than RS-AF-MPCs
We next examined the expression of the oct-4, sox-2 and nanog transcripts, key markers in embryonic stem cells and responsible for the maintenance of pluripotency of mammalian stem cells in vivo and in vitro, in SS-AF-MPCs and RS-AF-MPCs of passages 5-7 [34, 35]. Oct-4, nanog and sox-2 exhibited a 2.6Ϯ1.38, 10.41 Ϯ 3.38 and 15.18 Ϯ 3.92 fold higher expression respectively, in SS-AF-MPCs compared to RS-AF-MPCs, by RT-PCR analysis after normalization to GAPDH endogenous control (Fig. 5A). However, both AF-MPCs types expressed Oct-4 and Sox-2 at protein level, as demonstrated by nuclear immunofluorescent staining
SS-AF-MPCs exhibited different differentiation properties compared to RS-AF-MPCs
SS-AF-MPCs and RS-AF-MPCs were cultured under appropriate conditions that induce adipocytes, osteocytes, chondrocytes (mesoderm-derived) and hepatocytes (endoderm-derived), to evaluate their in vitro differentiation properties
expression alteration according to the proliferation rate of SS-AF-MPCs. (A) Comparative analysis of the percentage of proliferation increase of SS-AF-MPCs at 37ЊC (grey line) and 33ЊC (light grey line), respectively during 6 days of culture. (B) Comparison of the percentage of expression of CD73, CD105 and CD90 (i) at day 1 and (ii) day 6 of culture at 37ЊC (grey bars) and 33ЊC (light grey bars) by FACS analysis, respectively. MFI values were normalized for each marker against the level of expression determined at 37ЊC, which was set to 100%. Values are shown as mean Ϯ S.D. for three independent experiments. Statistical analysis was performed using the Student's t-test (*P Ͻ 0.05; **P Ͻ 0.001). and hepatogenic inducing conditions, RS-AF-MPCs failed to form chondrocytes and hepatocyte-like cells respectively, in contrast to SS-AF-MPCs
. Hepatogenesis was verified by PAS staining, where hepatocyte-like cells derived from SS-AF-MPCs exhibited a 73.07 Ϯ 5.2 fold times increase in PAS staining compared to SS-AF-MPCs
fold expression difference compared to SS-AF-MPCs)
Differentially expressed proteins identified in SS-AF-MPCs and RS-AF-MPCs
To further characterize the AF-MPCs subpopulations, proteins differentially expressed in SS-AF-MPCs and RS-AF-MPCs were identified by 2D-gel electrophoreses and MS. Total protein extracts of three different SS-AF-MPCs and RS-AF-MPCs preparations were analysed in duplicate by 2DE in 4-7 pH gradient strips. The derived pattern of resolved protein spots for each cell type was highly consistent and a comparison of the expression levels of the respective proteins was established using PDQuest 8 software (
Among the proteins overexpressed in SS-AF-MPCs, collagen ␣1 (I), a major extracellular matrix molecule responsible for directing the fate of MSCs into osteogenic lineages [36], was the most abundant. This finding may in turn explain the enhanced differentiation potential of SS-AF-MPCs to osteoblastic lineages, as observed in our in vitro studies. Proteins facilitating cell migration, such as Rho GDP-dissociation inhibitor 1
Fig. 4 Migration and adhesion properties of SS-AF-MPCs and RS-AF-MPCs. (A) (i) SS-AFMPCs showed higher motility (**P Ͻ 0.001) on fibronectin and laminin, respectively compared to RS-AF-MPCs. (ii) Number of migrated SS-AF-MPCs to fibronectin in presence of CD44 neutralizing antibody or isotype matched non-specific antibody IgG1. (iii) Representative image (20ϫ) of migrated SS-AF-MPCs fixed and stained using the Ral staining kit on the transwell membrane. (B) (i) Number of adherent SS-AF-MPCs and RS-AF-MPCs to fibronectin, treated with CD44, CD49e neutralizing antibodies or isotype matched nonspecific antibody IgG1 in comparison to non treated SS-AF-MPCs and RS-AF-MPCs, respectively. (ii) Number of adherent SS-AFMPCs and RS-AF-MPCs to hyalouronic acid, treated with CD44 neutralizing antibody or isotype matched non-specific antibody IgG1 in comparison to non treated SS-AF-MPCs and RS-AF-MPCs, respectively. (iii) Representative image (20ϫ) of adherent cells fixed and stained using the Ral staining kit on the plastic vessel. Values are shown as mean Ϯ S.D. for three independent experiments. Statistical analysis was carried out using the Student's t-test (*P Ͻ 0.05; **P Ͻ 0.001).
Confirmation of the differentially expressed proteins CK18, CK19, cathepsin B and collagen ␣1 (I)
RS-AF-MPCs exhibited a more complicated protein profile compared to SS-AF-MPCs, including 10 uniquely expressed proteins, supporting the indication of an earlier developmental stage of the SS population. To verify the 2DE results and confirm the differential expression, cytokeratin 18, cytokeratin 19 and cathepsin B were further analysed by Western blotting. It was demonstrated that bands of 40, 54 and 28 kD, corresponding to CK19, CK18 and cathepsin B, respectively were only detected in RS-AF-MPCs (Fig. 7C). Furthermore, collagen ␣1 (I) was expressed in higher levels in SS-AF-MPCs than in RS-AF-MPCs again in agreement to the 2DE results
Fig. 5 Embryonic stem cell marker expression and differentiation potential of SS-AF-MPCs and RS-AF-MPCs. (A) Comparative analysis for the expression of oct-4, nanog and sox-2 in three SS-AF-MPCs and RS-AF-MPCs samples, respectively, analysed by RT-PCR. Results were first normalized to human GAPDH positive control and then to SS-AF-MPCs expression levels for each marker, respectively. Statistical analysis was performed using the Student's t-test. (B) Immunofluorecent nuclear staining for (i-ii) Oct-4, (iii-iv) Sox-2 and (v-viii) DAPI (ix-xii) of SS-AF-MPCs and RS-AF-MPCs. Merge of DAPI staining and antibody staining. Original magnifications, 40ϫ.
Lentivirus-mediated gene transfer of AF-MPCs
Taking under consideration the successful, easy and rapid expansion of SS-AF-MPCs in culture, as well as the high passage they reach compared to RS-AF-MPCs, we further investigated whether they can be efficiently transduced with lentiviral vectors for further potential use in in vivo therapeutic applications. For this reason, SS-AF-MPCs were transduced with GFP third generation lentivirus
properties of (i) SS-AF-MPCs and (ii) RS-AF-MPCs respectively, followed by (iii) quantitation analysis. (B) Alkaline phosphatase staining for osteocyte differentiation for (i) SS-AF-MPCs and (ii) RS-AFMPCs respectively, followed by (iii) quantitation analysis. (C) (i) Alcian Blue and (ii) haematoxylin and eosin staining of SS-AFMPCs, cultured under chondrogenic inducing conditions in pellet mass cultures. (D) PAS staining for hepatocyte differentiation for (i) SS-AF-MPCs induced to hepatocytes. (ii) Quantitation analysis for PAS staining, (iii) determination of the secreted Urea and (iv) albumin expression were shown. Quantitation of the respective differentiation assays was performed by using the
. The expression levels of mesenchymal markers (CD90, CD105 and CD73) in SS-AF-MPCs remained the same after transduction (data not shown).
Furthermore, we performed a different passage expression analysis using SS-AF-MPCs of passages 10-40, transduced with an MOI of 60 (Fig. 8D) . Interestingly enough, the passage did not affect the expression of GFP. In addition, the expression of GFP was maintained at the same high levels 4 weeks and 9 months post-transduction (Fig. 8E) Figure S1C .
In vivo engraftment of left ventricular transduced SS-AF-MPCs
The high proliferation rate of SS-AF-MPCs and the fact that they exhibit normal karyotype at high passages, allowed the use of these cells in vivo. RS-AF-MPCs were not efficient in number to be used in in vivo experiments. (Fig. 9) . For immunohistochemistry antihuman CD90 antibody, which does not cross-react with mouse MSCs and tissue (Fig. S1D) 
Thus, we further investigated the in vivo survival, migration and engraftment of GFP-SS-AF-MPCs in non-damaged immunosupressed mice. GFP-SS-AF-MPCs were i.v. injected into NOD/SCID mice and then analyses involving FACS, immunohistochemistry and RT-PCR for the WPRE gene were used, to follow the distribution of donor cells 4 and 10 days post-injection at different tissues
Fig. 9 In vivo engraftment of GFP transduced SS-AF-MPCs. (A) GFP-SS-AF-MPCs were trapped in different tissues as evaluated by immunohistochemistry, 4 and 10 days after transplantation. GFP-SS-AF-MPCs were found in liver, spleen, lung and kidney at low frequency. Immunohistochemistry was performed by using anti-GFP antibody. Quantitation of GFP cells was determined by (B) FACS analysis and (C) RT-PCR in the respective tissues 4 or 10 days post-injection where percentage of positive cells and GFP fold expression difference is presented, respectively. As negative controls, non-injected mice were used. Values are shown as mean Ϯ S.D. for four mice in each group. (D) (i) Representative post-mortem fluorescent microscopy image of SS-AF-MPCs within the matrigel revealed a robust engraftment. (ii) FACS analysis of the disassociated matrigel area in presence of GFP transduced SS-AFMPCs (red filled histogram) or GFP transduced SS-AF-MPCs in PBS (open histogram) 1 and 10 days post-transplantation.
Discussion
Recent interest is focused on AF as a valuable source of MPCs [7-9, 11, 12] . Culture of AF-MPCs, as previously reported from our group and others, yielded in an adherent heterogenic cell population with diverse morphology [7, 8, 11] . The expression analysis, determined by FACS analysis, documented the presence of CD44, CD90, CD73 and CD105 and the absence of haematopoietic-related CD-antigens [7, 8, 11] , resembling to the phenotype of MSC-like cells according to standard criteria [43] .
In our previous studies, we successfully isolated and expanded karyotypically normal MSCs from 80 samples of second trimester AF and performed a systematic phenotypic, molecular and proteomic analysis [7] . The [7] .
In [3, 4, 6-9, 11, 13, 16, 44] . Other groups have reported that the existence of morphologically distinct MPC subpopulations is related to the plating density of the sample [1, 4, 44] [7, 49] [6, 7, 9, 11, 31] (20) ], at passage 32. Forty metaphase spreads were fully analysed and karyotyped in each case. 
(C) GFP transduced SS-AF-MPCs differentiation to adipocyte, osteocytes and hepatocytes. (D) Representative FACS histograms of SS-AF-MPCs (black filled histograms) and mouse BM-MSCs (grey filled histograms) gated for CD90, prior to analysis with the isotype-matched negative controls (blue and red open histograms), respectively. (E) Normal karyotype of (i) SS-AF-MPCs and (ii) RS-AF-MPCs from two representative samples derived from male [46XY(20)] and female embryo [46XX(20)], respectively at passage 5. (iii) Normal karyotype of SS-AF-MPCs from 1 representative sample derived from female embryo [46XX
Table S1 Proteins up-regulated in SS-AF-MPCs
